Genmab — September 2020

[Solsen]

Imponerende ganske enkelt !

[Mcjean]

Yep! Tak til Genmab for at give folk håb.

[Helge_LarsenPI-redaktør]

Novo også drønstærk i dag.

[Bulder]

Det her er kun begyndelsen på tiso. Der er større forventninger til andre kræftformer. F,eks, bugspytkirtlen, hvor præklinikken så god ud. Desuden vil der komme kombinationsbehandlinger.

[bikube]

Det eneste jeg har, der ikke er rødt i dag er mine Bear Tesla.

[GeorgeBest]

.@rcoledude presents results from the InnovaTV trial of tisotumab vedotin. There was a 24% response rate in patients w/ recurrent #cervical cancer, >50% of patients had stable disease beyond 6 months! https://twitter.com/shannonwestin/status/1308062372075122688?s=21

[Solsen]

https://twitter.com/seattlegenetics/status/1308048587255771136?s=21 Annonce på Twitter siger 13.800+ nye cervical patienter i US årligt. Så stort marked og de har vel også åbnet for at tiso kunne blive blockbuster. Vi har vel heller ikke set weekly behandling, som forventes med bedre resultat.

[E_L]

and Europe is a multiple of that, i think 3 or 4 times as much. we had an article here about it , but can't remember where

[E_L]

the real drama is offcourse in developing countries. a few hundred thousand....

[E_L]

maybe it was in the annual report

[Solsen]

Many i Japan...

[GeorgeBest]

Yes, Japan is very important, they don‘t give their teenage girls the hpv vaccine

[peter12]

On the latest fireside session JvdW said that Europe would require larger trials for TV

[Sukkeralf]

https://endpts.com/esmo20-seattle-genetics-eyes-4th-approval-with-new-data-in-a-crowded-field/

[Helge_LarsenPI-redaktør]

God morgen.

[transalp]

Go morgen..

[bibob]

God morgen.

[bibob]

Tisotumab på ESMO. https://www.onclive.com/view/tisotumab-vedotin-elicits-encouraging-responses-in-recurrent-metastatic-cervical-cancer?utm_source=sfmc&utm_medium=email&utm_campaign=9-21-20-_IMM-20-OGD0777_OncLiveSS_ESMO GLOBAL Conference Coverage eNews_Immunomedics_Trodelv&eKey=

[E_L]

same guy at youtube https://www.youtube.com/watch?v=ytGEecu6vrU

[E_L]

Stephen L. Hauser, MD: Ofatumumab in Treatment-Naïve Patients With MS https://www.youtube.com/watch?v=Uz7OUaCIyfU